Synthesis of 2-aryl-6-methyl-5-nitroquinoline derivatives as potential prodrug systems for reductive activation

Tetrahedron

Volumn 64, Issue 12, 2008, Pages 2816-2823

  Couch, Gavin D ^a   Burke, Philip J ^b   Knox, Richard J ^b   Moody, Christopher J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Morvus Technology Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (FUR 2 YL) 5 NITROQUINOLINE 6 METHANOL; 2 (NAPHTH 1 YL) 5 NITROQUINOLINE 6 METHANOL; 2 (NAPHTH 2 YL) 5 NITROQUINOLINE 6 METHANOL; 2 ARYL 5 NITROQUINOLINE 6 METHANOL; 2 CHLORO 5 NITROQUINOLINE 6 METHANOL; 5 NITRO 2 (2 THIENYL)QUINOLINE 6 METHANOL; 5 NITRO 2 PHENYLQUINOLINE 6 METHANOL; 5 NITROQUINOLINE; 5 NITROQUINOLINE 6 METHANOL; 6 (DIBROMOMETHYL) 5 NITROQUINOLINE; 6 ACETOXYMETHYL 2 CHLORO 5 NITROQUINOLINE; 6 ACETOXYMETHYL 5 NITROQUINOLINE; 6 BROMOMETHYL 5 NITRO 2 (THIEN 2 YL)QUINOLINE; 6 BROMOMETHYL 5 NITRO 2 PHENYLQUINOLINE; BROMOFORM; CHLORINE; HYMECROMONE; METHYL GROUP; NITROQUINOLINE DERIVATIVE; PALLADIUM; PRODRUG; QUINOLINE 6 METHANOL; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROLYSIS; PRIORITY JOURNAL; REDUCTION; SUBSTITUTION REACTION; SUZUKI REACTION;

EID: 39149098433     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2008.01.043     Document Type: Article

References (26)

1. Melton R.G., and Knox R.J. Enzyme Prodrug Strategies for Cancer Therapy (1999), Kluwer Academic/Plenum, New York, NY
2. Jaffar M., Williams K.J., and Stratford I.J. Adv. Drug Delivery Rev. 53 (2001) 217-228
3. Naylor M.A., and Thomson P. Mini Rev. Med. Chem. 1 (2001) 17-29
4. Skelly J.V., Knox R.J., and Jenkins T.C. Mini Rev. Med. Chem. 1 (2001) 293-306
5. Wardman P. Curr. Med. Chem. 8 (2001) 739-761
6. Denny W.A. Curr. Pharm. Design 8 (2002) 1349-1361
7. Knox R.J., Burke P.J., Chen S., and Kerr D.J. Curr. Pharm. Design 9 (2003) 2091-2104
8. Jiang Y.Y., Han J.Y., Yu C.Z., Vass S.O., Searle P.F., Browne P., Knox R.J., and Hu L.Q. J. Med. Chem. 49 (2006) 4333-4343
9. Hu L.Q., Yu C.Z., Jiang Y.Y., Han J.Y., Li Z.R., Browne P., Race P.R., Knox R.J., Searle P.F., and Hyde E.I. J. Med. Chem. 46 (2003) 4818-4821
10. Hay M.P., Atwell G.J., Wilson W.R., Pullen S.M., and Denny W.A. J. Med. Chem. 46 (2003) 2456-2466
11. Asche C., Dumy P., Carrez D., Croisy A., and Demeunynck M. Bioorg. Med. Chem. Lett. 16 (2006) 1990-1994
12. Sykes B.M., Hay M.P., Bohinc-Herceg D., Helsby N.A., O'Connor C.J., and Denny W.A. J. Chem. Soc., Perkin Trans. 1 (2000) 1601-1608
13. Hay M.P., Wilson W.R., and Denny W.A. Bioorg. Med. Chem. 13 (2005) 4043-4055
14. Atwell G.J., Sykes B.M., O'Connor C.J., and Denny W.A. J. Med. Chem. 37 (1994) 371-380
15. Lee H.H., Palmer B.D., Wilson W.R., and Denny W.A. Bioorg. Med. Chem. Lett. 8 (1998) 1741-1744
16. Parveen I., Naughton D.P., Whish W.J.D., and Threadgill M.D. Bioorg. Med. Chem. Lett. 9 (1999) 2031-2036
17. Ferrer S., Naughton D.P., Parveen I., and Threadgill M.D. J. Chem. Soc., Perkin Trans. 1 (2002) 335-340
18. Ferrer S., Naughton D.P., and Threadgill M.D. Tetrahedron 59 (2003) 3437-3444
19. Reigan P., Edwards P.N., Gbaj A., Cole C., Barry S.T., Page K.M., Ashton S.E., Luke R.W.A., Douglas K.T., Stratford I.J., Jaffar M., Bryce R.A., and Freeman S. J. Med. Chem. 48 (2005) 392-402
20. Zhang Z., Tanabe K., Hatta H., and Nishimoto S. Org. Biomol. Chem. 3 (2005) 1905-1910
21. Thomson P., Naylor M.A., Everett S.A., Stratford M.R.L., Lewis G., Hill S., Patel K.B., Wardman P., and Davis P.D. Mol. Cancer Ther. 5 (2006) 2886-2894
22. Fryatt T., Goroski D.T., Nilson Z.D., Moody C.J., and Beall H.D. Bioorg. Med. Chem. Lett. 9 (1999) 2195-2198
23. Fryatt T., Pettersson H.I., Gardipee W.T., Bray K.C., Green S.J., Slawin A.M.Z., Beall H.D., and Moody C.J. Bioorg. Med. Chem. 12 (2004) 1667-1687
24. Makosza M., and Owczarczyk Z. J. Org. Chem. 54 (1989) 5094-5100
25. Makosza M. Synthesis (1991) 103-112
26. James A.L., Perry J.D., and Stanforth S.P. J. Heterocycl. Chem. 43 (2006) 515-517